Cohen Klingenstein’s Eli Lilly LLY Stock Holding History

Cohen Klingenstein’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$155M	Sell	129,013 -45	-0%	-$46K	4.43%	5
2026 Q1	$119M	Sell	129,058 -935	-0.7%	-$948K	3.84%	5
2025 Q4	$140M	Sell	129,993 -230	-0.2%	-$220K	4.24%	5
2025 Q3	$99.4M	Hold	130,223	–	–	3.11%	8
2025 Q2	$102M	Sell	130,223 -241	-0.2%	-$187K	3.39%	7
2025 Q1	$108M	Hold	130,464	–	–	3.9%	5
2024 Q4	$101M	Sell	130,464 -8,000	-6%	-$6.62M	3.45%	8
2024 Q3	$123M	Hold	138,464	–	–	4.27%	6
2024 Q2	$125M	Sell	138,464 -1,798	-1%	-$1.44M	4.55%	6
2024 Q1	$109M	Sell	140,262 -70	-0%	-$49.8K	4.06%	7
2023 Q4	$81.8M	Sell	140,332 -2,234	-2%	-$1.3M	3.34%	8
2023 Q3	$76.6M	Hold	142,566	–	–	3.47%	7
2023 Q2	$66.9M	Sell	142,566 -299	-0.2%	-$125K	2.9%	9
2023 Q1	$49.1M	Hold	142,865	–	–	2.3%	11
2022 Q4	$52.3M	Sell	142,865 -2,535	-2%	-$899K	2.63%	11
2022 Q3	$47M	Hold	145,400	–	–	2.49%	10
2022 Q2	$47.1M	Hold	145,400	–	–	2.36%	10
2022 Q1	$41.6M	Hold	145,400	–	–	1.73%	12
2021 Q4	$40.2M	Sell	145,400 -50,000	-26%	-$12.7M	1.59%	13
2021 Q3	$45.1M	Sell	195,400 -6,300	-3%	-$1.55M	1.97%	10
2021 Q2	$46.3M	Hold	201,700	–	–	1.99%	11
2021 Q1	$37.7M	Hold	201,700	–	–	1.74%	12
2020 Q4	$34.1M	Hold	201,700	–	–	1.7%	11
2020 Q3	$29.9M	Sell	201,700 -900	-0.4%	-$139K	1.68%	11
2020 Q2	$33.3M	Hold	202,600	–	–	2.04%	9
2020 Q1	$28.1M	Hold	202,600	–	–	2.08%	10
2019 Q4	$26.6M	Hold	202,600	–	–	1.55%	13
2019 Q3	$22.7M	Buy	202,600 +10,000	+5%	+$1.11M	1.42%	14
2019 Q2	$21.3M	Sell	192,600 -10,000	-5%	-$1.18M	1.52%	13
2019 Q1	$26.3M	Buy	202,600 +108,000	+114%	+$13.1M	1.83%	12
2018 Q4	$10.9M	Hold	94,600	–	–	1.65%	11
2018 Q3	$10.2M	Hold	94,600	–	–	1.29%	13
2018 Q2	$8.07M	Hold	94,600	–	–	1.1%	16
2018 Q1	$7.32M	Hold	94,600	–	–	1.04%	17
2017 Q4	$7.99M	Hold	94,600	–	–	1.14%	15
2017 Q3	$8.09M	Hold	94,600	–	–	1.22%	13
2017 Q2	$7.79M	Hold	94,600	–	–	1.21%	13
2017 Q1	$7.96M	Hold	94,600	–	–	1.27%	13
2016 Q4	$6.96M	Hold	94,600	–	–	1.19%	14
2016 Q3	$7.59M	Hold	94,600	–	–	1.32%	13
2016 Q2	$7.45M	Hold	94,600	–	–	1.37%	12
2016 Q1	$6.81M	Hold	94,600	–	–	1.28%	13
2015 Q4	$7.97M	Hold	94,600	–	–	1.49%	11
2015 Q3	$7.92M	Hold	94,600	–	–	1.56%	12
2015 Q2	$7.9M	Hold	94,600	–	–	1.42%	13
2015 Q1	$6.87M	Hold	94,600	–	–	1.25%	17
2014 Q4	$6.53M	Hold	94,600	–	–	1.22%	21
2014 Q3	$6.13M	Hold	94,600	–	–	1.08%	23
2014 Q2	$5.88M	Hold	94,600	–	–	1.12%	23
2014 Q1	$5.57M	Hold	94,600	–	–	1.11%	22
2013 Q4	$4.83M	Hold	94,600	–	–	0.96%	24
2013 Q3	$4.76M	Sell	94,600 -800	-0.8%	-$41.9K	1.04%	23
2013 Q2	$4.69M	Buy	+95,400	New	+$5.19M	1.09%	21

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Cohen Klingenstein's LLY Position: Q2 2026 in Review

Cohen Klingenstein reduced its Eli Lilly (LLY) stake by 0.03% in Q2 2026, selling an estimated $46K and leaving 129,013 shares worth $155M. The position accounts for 4.43% of the portfolio, ranked #5.

Cohen Klingenstein first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Cohen Klingenstein held 129,013 shares of Eli Lilly worth $155M as of Q2 2026.
Cohen Klingenstein sold 45 Eli Lilly shares in Q2 2026, an estimated $46K.
Eli Lilly made up 4.43% of Cohen Klingenstein's portfolio in Q2 2026, its #5 holding.
Cohen Klingenstein first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cohen Klingenstein's 13F filing for Q2 2026, filed 15 Jul 2026.